# PMAIP1

## Overview
PMAIP1, also known as NOXA, is a gene that encodes the pro-apoptotic protein phorbol-12-myristate-13-acetate-induced protein 1. This protein is a member of the Bcl-2 family, specifically categorized as a BH3-only protein, which plays a critical role in the intrinsic pathway of apoptosis. NOXA is characterized by its intrinsically disordered structure, which allows it to interact with various molecular partners, primarily targeting anti-apoptotic proteins such as MCL1 and BCL2A1 for degradation. This interaction is crucial for promoting mitochondrial outer membrane permeabilization and the subsequent activation of caspases, leading to programmed cell death (Janus2020Prodeath). The expression of PMAIP1 is regulated by stress stimuli and transcription factors, contributing to cellular homeostasis by eliminating damaged or stressed cells, thereby preventing tumorigenesis (Gu2010A). The gene's activity is predominantly localized to the mitochondria, where it facilitates the apoptotic process (Janus2020Prodeath).

## Structure
PMAIP1, also known as NOXA, is a pro-apoptotic protein that belongs to the Bcl-2 family. It is characterized by the presence of a BH3 domain, which is essential for its interaction with anti-apoptotic proteins. The primary structure of NOXA is notable for its abundance of proline and serine residues, contributing to its intrinsically disordered nature. This lack of a defined tertiary or quaternary structure is a hallmark of NOXA, as it does not adopt a stable three-dimensional conformation under physiological conditions. 

The protein's disordered nature allows it to interact flexibly with various molecular partners, a feature that is often regulated by post-translational modifications. Phosphorylation is a key modification that influences NOXA's stability and function, potentially affecting its role in apoptotic pathways. Despite its structural disorder, the BH3 domain remains a critical element for its pro-apoptotic activity, facilitating the binding to and neutralization of anti-apoptotic Bcl-2 family members. 

NOXA does not have any known splice variant isoforms that significantly alter its function or structure. The combination of its disordered regions and specific domain interactions underscores its role in cellular apoptosis regulation.

## Function
PMAIP1, also known as NOXA, is a pro-apoptotic member of the Bcl-2 protein family, primarily involved in the intrinsic pathway of apoptosis. It functions as a BH3-only protein, which sensitizes cells to apoptosis by interacting with and neutralizing anti-apoptotic proteins such as MCL1 and BCL2A1. This interaction leads to the degradation of these proteins, promoting mitochondrial outer membrane permeabilization, the release of cytochrome c, and the activation of caspases, which are crucial for programmed cell death (Janus2020Prodeath).

PMAIP1 is induced by various stress stimuli, including DNA damage, hypoxia, and heat shock, and can be regulated by multiple transcription factors such as p53, HSF1, and others. Its expression is upregulated in response to stress conditions, contributing to apoptosis by disrupting mitochondrial integrity (Janus2020Prodeath; Gu2010A). In healthy human cells, PMAIP1 plays a significant role in maintaining cellular homeostasis by ensuring the removal of damaged or stressed cells, thus preventing tumorigenesis (Janus2020Prodeath). The gene's activity is primarily localized to the mitochondria, where it facilitates the apoptotic process (Janus2020Prodeath).

## Clinical Significance
Alterations in the expression of the PMAIP1 gene, which encodes the pro-apoptotic protein NOXA, have been implicated in various cancers. In mantle cell lymphoma (MCL), there is a notable discrepancy between high NOXA mRNA levels and low protein levels due to rapid ubiquitination and proteasomal degradation. This discrepancy is crucial for the sensitivity of MCL cells to ubiquitin-proteasome system inhibitors like Bortezomib, which induce apoptosis by targeting NOXA. The study suggests that targeting NOXA regulation could offer new therapeutic strategies for MCL, especially in Bortezomib-resistant cases (Dengler2014Discrepant).

In spinal cord glioma, PMAIP1 expression is significantly decreased compared to normal tissues, which is associated with reduced apoptosis. The long non-coding RNA LOC101928963 is overexpressed in glioma and may downregulate PMAIP1, contributing to tumor progression. Silencing LOC101928963 upregulates PMAIP1, inhibiting cell proliferation and promoting apoptosis, suggesting a potential therapeutic target (Zheng2019Silencing).

In metastatic melanoma, D-penicillamine treatment upregulates NOXA, leading to mitochondrial apoptosis. This process involves the downregulation of anti-apoptotic proteins like Mcl-1, highlighting the role of PMAIP1 in apoptosis and its potential as a therapeutic target (Qiao2012dPenicillamine).

## Interactions
PMAIP1, also known as NOXA, is a pro-apoptotic member of the Bcl-2 protein family that interacts with several proteins to promote apoptosis. It primarily interacts with anti-apoptotic proteins such as MCL1 and BCL2A1, targeting them for degradation and neutralizing their anti-apoptotic activity. This interaction leads to the activation of caspase-9 and apoptosis (Janus2020Prodeath). PMAIP1 does not directly bind to BAX or BAK1 but indirectly promotes mitochondrial dysfunction by inhibiting anti-apoptotic BCL2 family members, facilitating apoptosis in hepatocellular carcinoma cells (Kuo2011Involvement).

In the context of bladder cancer cells, PMAIP1 interacts with MCL1, promoting its ubiquitination and degradation, which is crucial for apoptosis. This interaction is part of the PMAIP1-USP9X-MCL1 axis, where the deubiquitinase USP9X stabilizes MCL1, but its levels are reduced, further promoting MCL1 degradation (Cui2015EHMT2). PMAIP1 also interacts with the long non-coding RNA PRINS in colorectal adenocarcinoma cells, where PRINS may protect PMAIP1 from RNase digestion through specific binding, influencing its availability and function (Hanisch2017TFF3dependent). These interactions highlight PMAIP1's role in modulating apoptosis through various pathways and protein interactions.


## References


[1. (Dengler2014Discrepant) M A Dengler, A Weilbacher, M Gutekunst, A M Staiger, M C Vöhringer, H Horn, G Ott, W E Aulitzky, and H van der Kuip. Discrepant noxa (pmaip1) transcript and noxa protein levels: a potential achilles’ heel in mantle cell lymphoma. Cell Death &amp; Disease, 5(1):e1013–e1013, January 2014. URL: http://dx.doi.org/10.1038/cddis.2013.552, doi:10.1038/cddis.2013.552. This article has 48 citations.](https://doi.org/10.1038/cddis.2013.552)

[2. (Qiao2012dPenicillamine) Shuxi Qiao, Christopher M. Cabello, Sarah D. Lamore, Jessica L. Lesson, and Georg T. Wondrak. D-penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (upr) and noxa (pmaip1)-dependent mitochondrial apoptosis. Apoptosis, 17(10):1079–1094, July 2012. URL: http://dx.doi.org/10.1007/s10495-012-0746-x, doi:10.1007/s10495-012-0746-x. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10495-012-0746-x)

[3. (Janus2020Prodeath) Patryk Janus, Agnieszka Toma-Jonik, Natalia Vydra, Katarzyna Mrowiec, Joanna Korfanty, Marek Chadalski, Piotr Widłak, Karolina Dudek, Anna Paszek, Marek Rusin, Joanna Polańska, and Wiesława Widłak. Pro-death signaling of cytoprotective heat shock factor 1: upregulation of noxa leading to apoptosis in heat-sensitive cells. Cell Death &amp; Differentiation, 27(7):2280–2292, January 2020. URL: http://dx.doi.org/10.1038/s41418-020-0501-8, doi:10.1038/s41418-020-0501-8. This article has 23 citations.](https://doi.org/10.1038/s41418-020-0501-8)

[4. (Kuo2011Involvement) Kung-Kai Kuo, Yi-Ling Chen, Lih-Ren Chen, Chien-Feng Li, Yu-Hsuan Lan, Fang-Rong Chang, Yang-Chang Wu, and Yow-Ling Shiue. Involvement of phorbol-12-myristate-13-acetate-induced protein 1 in goniothalamin-induced tp53-dependent and -independent apoptosis in hepatocellular carcinoma-derived cells. Toxicology and Applied Pharmacology, 256(1):8–23, October 2011. URL: http://dx.doi.org/10.1016/j.taap.2011.07.002, doi:10.1016/j.taap.2011.07.002. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.taap.2011.07.002)

[5. (Cui2015EHMT2) Jing Cui, Wendong Sun, Xuexi Hao, Minli Wei, Xiaonan Su, Yajing Zhang, Ling Su, and Xiangguo Liu. Ehmt2 inhibitor bix-01294 induces apoptosis through pmaip1-usp9x-mcl1 axis in human bladder cancer cells. Cancer Cell International, February 2015. URL: http://dx.doi.org/10.1186/s12935-014-0149-x, doi:10.1186/s12935-014-0149-x. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-014-0149-x)

[6. (Gu2010A) Jian Gu, Yuanqing Ye, Margaret R. Spitz, Jie Lin, Lambertus A. Kiemeney, Jingliang Xing, Michelle A. T. Hildebrandt, Waun Ki Hong, Christopher I. Amos, and Xifeng Wu. A genetic variant near the pmaip1/noxa gene is associated with increased bleomycin sensitivity. Human Molecular Genetics, 20(4):820–826, November 2010. URL: http://dx.doi.org/10.1093/hmg/ddq509, doi:10.1093/hmg/ddq509. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddq509)

[7. (Hanisch2017TFF3dependent) Carlos Hanisch, Jutta Sharbati, Barbara Kutz-Lohroff, Otmar Huber, Ralf Einspanier, and Soroush Sharbati. Tff3-dependent resistance of human colorectal adenocarcinoma cells ht-29/b6 to apoptosis is mediated by mir-491-5p regulation of lncrna prins. Cell Death Discovery, January 2017. URL: http://dx.doi.org/10.1038/cddiscovery.2016.106, doi:10.1038/cddiscovery.2016.106. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/cddiscovery.2016.106)

[8. (Zheng2019Silencing) Ying-Juan Zheng, Tian-Song Liang, Juan Wang, Jing-Yi Zhao, Dao-Ke Yang, and Zhang-Suo Liu. Silencing lncrna loc101928963 inhibits proliferation and promotes apoptosis in spinal cord glioma cells by binding to pmaip1. Molecular Therapy - Nucleic Acids, 18:485–495, December 2019. URL: http://dx.doi.org/10.1016/j.omtn.2019.07.026, doi:10.1016/j.omtn.2019.07.026. This article has 11 citations.](https://doi.org/10.1016/j.omtn.2019.07.026)